HCA Healthcare, Inc. (HCA)
HCA Healthcare, Inc. (HCA) carries a ŷRobot AI score of 65 out of 100. The model's fair value estimate is $452.40, 1.4% below the last close of $458.84. The chart signal reads Sell.
| Metric | HCA |
|---|---|
| AI score | 65 / 100 |
| Chart signal | Sell |
| Fair value estimate | $452.40 |
| Upside to fair value | -1.4% |
| Previous close | $458.84 |
| P/E | 14.47 |
| Price / sales | 1.20 |
| Market cap | $103.93B |
| EPS | 29.49 |
| Revenue growth | 7.6% |
| 1-year price change | 18.8% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Incorporated, Merck & Company Inc, Novartis AG ADR.
Questions about HCA
Is HCA overvalued or undervalued right now?
As of Oct 16, 2026, ŷRobot's fair-value model estimates HCA Healthcare, Inc. (HCA) at $452.40 against a last close of $458.84, implying 1.4% downside to the model's estimate.
Is HCA's chart signal bullish or bearish?
The chart-signal model classifies HCA as Neutral as of Oct 16, 2026, with a signal score of -0.11 on a -1 to 1 scale.
What is HCA's ŷRobot AI score?
HCA scores 65 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 16, 2026.
Is HCA stock expensive on P/E and P/S?
HCA trades at 14.5 times earnings and 1.2 times sales as of Oct 16, 2026.
What does HCA's seasonal forecast show?
ŷRobot's seasonal forecast curve for HCA reads +3.4% at 30 days, +12.0% at 90 days, and +18.8% at one year as of Oct 16, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is HCA growing?
HCA Healthcare, Inc.'s revenue growth is +7.6% and free-cash-flow growth is +1.4% on the latest reported figures.
HCA chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.